Shoham Natalie, Dunca Diana, Cooper Claudia, Hayes Joseph F, McQuillin Andrew, Bass Nick, Lewis Gemma, Kuchenbaecker Karoline
Division of Psychiatry, University College London, UK; and Islington Early Intervention Service, Camden and Islington NHS Foundation Trust, St Pancras Hospital, London, UK.
UCL Genetics Institute, University College London, UK.
BJPsych Open. 2023 Feb 7;9(2):e33. doi: 10.1192/bjo.2023.6.
Increased rates of visual impairment are observed in people with schizophrenia.
We assessed whether genetically predicted poor distance acuity is causally associated with schizophrenia, and whether genetically predicted schizophrenia is causally associated with poorer visual acuity.
We used bidirectional, two-sample Mendelian randomisation to assess the effect of poor distance acuity on schizophrenia risk, poorer visual acuity on schizophrenia risk and schizophrenia on visual acuity, in European and East Asian ancestry samples ranging from approximately 14 000 to 500 000 participants. Genetic instrumental variables were obtained from the largest available summary statistics: for schizophrenia, from the Psychiatric Genomics Consortium; for visual acuity, from the UK Biobank; and for poor distance acuity, from a meta-analysis of case-control samples. We used the inverse variance-weighted method and sensitivity analyses to test validity of results.
We found little evidence that poor distance acuity was causally associated with schizophrenia (odds ratio 1.00, 95% CI 0.91-1.10). Genetically predicted schizophrenia was associated with poorer visual acuity (mean difference in logMAR score: 0.024, 95% CI 0.014-0.033) in European ancestry samples, with a similar but less precise effect that in smaller East Asian ancestry samples (mean difference: 0.186, 95% CI -0.008 to 0.379).
Genetic evidence supports schizophrenia being a causal risk factor for poorer visual acuity, but not the converse. This highlights the importance of visual care for people with psychosis and refutes previous hypotheses that visual impairment is a potential target for prevention of schizophrenia.
在精神分裂症患者中观察到视力损害发生率增加。
我们评估了基因预测的远距离视力差是否与精神分裂症存在因果关系,以及基因预测的精神分裂症是否与较差的视力存在因果关系。
我们使用双向两样本孟德尔随机化方法,在欧洲和东亚血统样本中(参与者约14000至500000人)评估远距离视力差对精神分裂症风险的影响、较差视力对精神分裂症风险的影响以及精神分裂症对视力的影响。基因工具变量来自可获得的最大汇总统计数据:精神分裂症的数据来自精神疾病基因组学联盟;视力的数据来自英国生物银行;远距离视力差的数据来自病例对照样本的荟萃分析。我们使用逆方差加权法和敏感性分析来检验结果的有效性。
我们几乎没有发现证据表明远距离视力差与精神分裂症存在因果关系(优势比1.00,95%置信区间0.91 - 1.10)。在欧洲血统样本中,基因预测的精神分裂症与较差的视力相关(logMAR评分的平均差异:0.024,95%置信区间0.014 - 0.033),在较小的东亚血统样本中也有类似但不太精确的效应(平均差异:0.186,95%置信区间 - 0.008至0.379)。
基因证据支持精神分裂症是视力较差的一个因果风险因素,但反之不成立。这凸显了对精神病患者进行视力护理的重要性,并反驳了先前关于视力损害是预防精神分裂症潜在靶点的假设。